Stay updated on Daratumumab in Pediatric/Young Adult ALL/LL Clinical Trial
Sign up to get notified when there's something new on the Daratumumab in Pediatric/Young Adult ALL/LL Clinical Trial page.

Latest updates to the Daratumumab in Pediatric/Young Adult ALL/LL Clinical Trial page
- Check2 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedLocations section added listing all study sites by state (Alabama, Arizona, California, Colorado, Connecticut, Georgia, Illinois, Indiana, Maryland, Massachusetts, Michigan, Missouri, New Jersey, New York, Ohio, Pennsylvania, Texas, Utah, Wisconsin) and HHS Vulnerability Disclosure removed; revision updated to v3.3.3.SummaryDifference1%

- Check45 days agoChange DetectedMinor metadata update: Revision v3.3.2 was added and v3.3.1 was removed; there are no changes to the study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedPublications section text updated to clarify entries are automatically filled from PubMed and may not reflect only the study content, and a revision label 'Revision: v3.3.1' was added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedThe notice about government funding delays and operating status was removed from the page, removing guidance on checking current status (cc.nih.gov) and updates (opm.gov).SummaryDifference0.2%

- Check74 days agoChange DetectedThe new screenshot shows no changes to core content such as the study overview, inclusion/exclusion criteria, endpoints, or locations; differences appear limited to formatting or layout adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Daratumumab in Pediatric/Young Adult ALL/LL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab in Pediatric/Young Adult ALL/LL Clinical Trial page.